Dopamine News and Research

Latest Dopamine News and Research

Antioxidant precursor molecule could improve dopamine levels in Parkinson's patients

N-acetylcysteine (NAC) is a naturally occurring molecule that replenishes one of the body's antioxidants and now shows potential benefit as part of a standard course of treatment for patients with Parkinson's disease, according to a study published in the journal, Clinical Pharmacology & Therapeutics.

16 Jul 2019

Genetic contribution to distractibility helps explain procrastination

Wouldn’t it be nice to blame your genes for your procrastination? Now, using a combination of questionnaires and genetic testing, German researchers have found that with increasing dopamine in the brain, women tended to show greater tendencies to procrastinate.

14 Jul 2019

Drinking Matcha tea may reduce anxious behavior, research shows

Many different countries have a tea culture, and Japanese Matcha tea is growing in popularity around the world. In Japan, Matcha has a long history of being used for various medicinal purposes. It has been suspected to have various beneficial effects to health, but relatively little scientific evidence supported that claim.

9 Jul 2019

Scientists create powerful method for 'directed evolution' of molecules

UNC School of Medicine scientists created a powerful new "directed evolution" technique for the rapid development of scientific tools and new treatments for many diseases.

5 Jul 2019

UK charity invests £1 million to develop potential therapeutic for Parkinson's

Charity Parkinson's UK is partnering with NRG Therapeutics Ltd to discover and develop a potential drug that could safeguard dopamine cells that are damaged by Parkinson's and slow down the progression of the condition.

1 Jul 2019

Opioids are major cause of pregnancy-related deaths in Utah

Stephanie lay in the Salt Lake County jail bunk bed and thought, "Everything would be better if I just died."

28 Jun 2019

Compelling New Evidence Further Suggests Parkinson’s Disease Begins in the Gut

A new mouse study has revealed more evidence that Parkinson’s disease originates in the gut before traveling to the brain via the body’s neurons.

27 Jun 2019

Scientists discover new drug target for chemically induced Parkinson's disease

More than three decades ago, scientists discovered that a chemical found in a synthetic opioid, MPTP, induced the onset of a form of Parkinson's disease.

23 Jun 2019

Scientists identify early signs of Parkinson’s disease years before symptoms develop

Scientists have identified the earliest signs of Parkinson’s disease in the brain up to 20 years before patients present with any symptoms.

20 Jun 2019

Scientists identify potential target for Parkinson's treatment

An international research team led by scientists at the University of Alabama at Birmingham has identified a potential target for therapeutics that might help slow the progression of Parkinson's disease.

12 Jun 2019

Study offers hope to slow down or prevent progression of Parkinson’s

Results from a study published today looking at a molecule targeting clumps of alpha-synuclein, a key protein linked to Parkinson’s, offers hope that it may be possible to slow down or prevent the progression of the condition in humans.

6 Jun 2019

Chronic inflammation removes motivation by reducing dopamine in the brain

Why do we feel listless when we are recovering from an illness? The answer is, apparently, that low-grade chronic inflammation interferes with the dopaminergic signaling system in the brain that motivates us to do things.

5 Jun 2019

Georgetown University Medical Center announces launch of clinical trial for Lewy body dementia

Georgetown University Medical Center announces the launch of the only known therapeutic (disease modifying) clinical trial for Lewy body dementia, a neurological disorder that affects a million people in the United States for which there are no approved medications that modify the disease.

3 Jun 2019

Patients with bipolar disorder are seven times more likely to develop Parkinson's

A new study has found that patients with bipolar disorder are seven times more likely to develop Parkinson’s disease.

23 May 2019

Neonatal exposure to nicotine alters neurons, predisposes brain to addiction in adulthood

Neonatal exposure to nicotine alters the reward circuity in the brains of newborn mice, increasing their preference for the drug in later adulthood, report researchers at University of California San Diego School of Medicine in a study published "in press" April 24, 2019 in Biological Psychiatry.

22 May 2019